Febuxostat pretreatment attenuates myocardial ischemia/reperfusion injury via mitochondrial apoptosis

BACKGROUND: Febuxostat is a selective inhibitor of xanthine oxidase (XO). XO is a critical source of reactive oxygen species (ROS) during myocardial ischemia/reperfusion (I/R) injury. Inhibition of XO is therapeutically effective in I/R injury. Evidence suggests that febuxostat exerts antioxidant ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shulin, Li, Yunpeng, Song, Xudong, Wang, Xianbao, Zhao, Cong, Chen, Aihua, Yang, Pingzhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4489215/
https://www.ncbi.nlm.nih.gov/pubmed/26136232
http://dx.doi.org/10.1186/s12967-015-0578-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4489215/
https://www.ncbi.nlm.nih.gov/pubmed/26136232
http://dx.doi.org/10.1186/s12967-015-0578-x

Ejemplares similares